PRAC's decision clearly puts what was wrong with FDA's action. FDA should have done exactly what PRAC did - do their due diligence appropriately and as the decision clearly puts it, the risk-reward is heavily biased towards the reward. I remember the comment by Pazdur which clearly put the motivation behind FDA's or his move... which was not certainly what PRAC followed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.